MK-2206
Revision as of 09:58, 28 November 2018 by imported>Xenbase
Description
"An orally potent and highly selective non-ATP-competitive allosteric Akt inhibitor that has nanomolar IC50 values and broad preclinical anti-tumor activities. Source: [1]
Alternative names
- MK 2206
- MK2206
Usage Notes
References